Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this insightful session on understanding the Evolution in Treatment and Diagnosis of Lung Cancer. Manipal Hospitals, a leader in advanced medical care, is proud to present this initiative led by the esteemed Dr. Lalit Sharma. From conventional approaches to groundbreaking targeted therapies and immunotherapies, lung cancer treatment has undergone a significant transformation, offering renewed hope and improved outcomes for patients worldwide. This session aims to delve into these pivotal advancements, highlighting how a comprehensive understanding of evolving diagnostic tools and therapeutic strategies is paramount for delivering personalized and effective patient care.
The landscape of lung cancer management has been revolutionized by innovations in both diagnosis and treatment. Early detection, often facilitated by advanced imaging and novel biopsy techniques, now paves the way for more precise staging and tailored interventions. Furthermore, the advent of molecular profiling, including Next-Generation Sequencing (NGS), allows healthcare providers to identify specific genetic mutations within tumors, such as EGFR, ALK, ROS1, and BRAF. This precision medicine approach enables the selection of targeted therapies that directly address the underlying drivers of cancer, significantly enhancing efficacy and minimizing side effects compared to traditional chemotherapy.
Join us to gain comprehensive knowledge on the latest best practices in the evolution of lung cancer treatment and diagnosis. Dr. Lalit Sharma will share invaluable insights on navigating this rapidly advancing field, empowering medical professionals with the knowledge to optimize patient care and improve survival rates. Listen to this essential webinar, absorb the shared expertise, and continue to follow Hidoc for more such enriching educational sessions designed to keep you at the forefront of medical innovation.
See More Webinars @ Hidoc Webinars
1.
In leukemia, allogeneic HCT is beneficial following primary induction failure.
2.
Team finds broken 'brake' on cancer mutation machine.
3.
Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer
4.
Prostate cancer screening program beneficial in top decile of polygenic risk score
5.
Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.
1.
New Research on Craniopharyngioma
2.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
5.
The Mysterious World of Petechiae: Exploring Causes and Treatments
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation